Prevalence and associated risk factors of type 2 diabetes mellitus in Nilufer District, Bursa, Turkey

International Journal of Diabetes and Metabolism

Volumn 14, Issue 2, 2006, Pages 98-102

  Aksu, Hurol ^a   Pala, Kayihan ^b   Aksu, Huseyin ^c  

^a Maternal and Child Health Center   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

District; Prevalence; Risk factor; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; RISK FACTOR; TURKEY (REPUBLIC);

EID: 34249084647     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Screening for Type 2 Diabetes. Report of a World Health Organization and International Diabetes Federation meeting. WHO/NMH/MNC/03.1. World Health Organization Department of Non communicable Disease Management, 2003, Geneva.
2. International Diabetes Federation. Diabetes Prevalence, 2005, http://www.idf.org/home/index.cfm?node=264.
3. Satman I, Yilmaz T, Sengul A, et al. Population-Based Study of Diabetes and Risk Characteristics in Turkey. Diabetes Care 2002; 25: 1551-1556.
4. NPHTRA Annual Report 2003.
5. Erem C, Yildiz R, Kavgaci H, et al. Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city), Diabetes Res Clin Pract 2001; 54: 203-208.
6. Report of a WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. WHO/NCD/NCS/99.2. World Health Organization Department of Non communicable Disease Surveillance, 1999, Geneva.
7. World Health Organization. Catalogue of Health Indicators: A Selection of Important Health Indicators Recommended by WHO Programmes, 1996, Geneva.
8. World Health Organization. Blood Safety and Clinical Technology Guidelines on Standard Operating Procedures for CLINICAL CHEMISTRY Glucose - Glucose Oxidase Method, 2005, http://w3.whosea.org/EN/Section10/Section17/ Section53/Section481_1753.htm.
9. Ozdemir L, Topcu S, Nadir I, et al. The Prevalence of Diabetes and Impaired Glucose Tolerance in Sivas, Central Anatolia, Turkey. Diabetes Care 2005; 28: 795-798.
10. Kelestimur F, Cetin M, Pasaoglu H, et al, The prevalence and identification of risk factors for type 2 diabetes mellitus and impaired glucose tolerance in Kayseri, Central Anatolia, Turkey. Acta Diabetol 1999; 36: 85-91.
11. Gokcel A, Ozsahin AK, Sezgin N, et al, High Prevalence of Diabetes in Adana, a Southern Province of Turkey. Diabetes Care 2003; 26: 3031-3034.
12. Nyenwe EA, Odia OJ, Ihekwaba AE, et al. Type 2 diabetes in adult Nigerian's: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract 2003; 62: 177-185.
13. Fletcher B, Gulanick M, Lamendola C.Risk Factors for Type 2 Diabetes Mellitus. J Cardiovasc Nurs 2002; 16: 17-23.
14. van der Sande MAB, Walraven GEL, Milligan PJM, et al. Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bulletin of the World Health Organization 2001; 79:321-328.
15. WHO, World Health Organization-International Society of Hypertension guidelines. Practice guidelines for primary care physicians, 1999.